Clinical trial COMPASS
COMPASS study - Comparison of different geriatric screening methods in newly diagnosed multiple myeloma patients, and assessment of therapeutic efficacy and toxicity in fit and frail patients. A multicenter observational Belgian study
| Cancers | |
|---|---|
| Organ | Myeloma |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Prospective observational study
|
| Academic trial | Oui |
| Sponsor | UZ-K.U.Leuven |
| BECT Identifier | B322201730801 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02918695 |
| Inclusion criteria | newly diagnosed multiple myeloma>= 70 years old |
| Last update |